Lifecore Biomedical Inc expected to post a loss of 23 cents a share - Earnings Preview

Lifecore Biomedical

02/10/2023 13:58

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to show a
fall in quarterly revenue when it reports  results 
    * The Chaska Minnesota-based  company is expected to report 
a
43.4% decrease in revenue to $24.545 million from $43.36 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lifecore Biomedical
Inc
is for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $9.5​, above​ its last closing price of $7.55.
​​​

The company's guidance on August 31 2023 for the period ended
August 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of of USD0.
This summary was machine generated October 2 at 12:58 GMT.  All
figures in US dollars  unless otherwise stated